At 92 weeks , patients who had treatments every 12 weeks had superior BCVA to those treated on an as-needed basis every 12 weeks ( P = 0.008 ) , with the regular treatment arm gaining a mean BCVA of 5.5 letters and the as-needed treatment arm gaining 0.6 letters .